CBDN — Cbd Global Sciences Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Cbd Global Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 0.022 | 0.001 | 0.093 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 0.358 | 0.003 | 0.024 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Current Assets | 3.77 | 0.308 | 0.32 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 2.2 | 0.08 | 1.38 |
| Net Goodwill | |||
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 6.15 | 0.472 | 2.09 |
| Accounts Payable | |||
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 5.77 | 3.55 | 2.06 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Total Other Liabilities | |||
| Total Liabilities | 7.31 | 8.75 | 3.79 |
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -1.16 | -8.28 | -1.7 |
| Total Liabilities & Shareholders' Equity | 6.15 | 0.472 | 2.09 |
| Total Common Shares Outstanding | |||
| Total Preferred Shares Outstanding |